Mapping of Domain Orientation and Molecular Order in Polycrystalline Semiconducting Polymer Films with Soft X‐Ray Microscopy

We utilize scanning transmission X‐ray microscopy (STXM) to study the domain structure of polycrystalline films of the semiconducting polymer poly(9,9’‐dioctylfluorene‐co‐benzothiadiazole) (F8BT). By taking several images at different orientations of the film with respect to the polarization of the X‐ray beam, we are able to compute quantitative maps of molecular alignment/order and molecular orientation, including both the backbone direction and phenyl ring plane orientation, as well as the in‐plane and out‐of‐plane components. We show that polycrystalline F8BT films consist of well‐ordered micron‐sized domains with the transition from one domain orientation to another characterized either by a smooth transition of orientation or by ～ 200 nm wide disordered domain boundaries. The morphology of the disordered domain boundaries resemble the electroluminescence patterns observed previously in F8BT light‐emitting field‐effect transistors suggesting that charge trapping at these disordered domain boundaries facilitates charge recombination in ambipolar operation. A relatively narrow distribution of local average tilt angles is observed that correlates with film structure, with the ordered domains in general showing a higher tilt angle than the disordered domain boundaries. We also use secondary electron detection to image the surface domain structure of polycrystalline F8BT films and demonstrate that the polycrystalline structure extends to the film/air interface. Finally, we calculate ideal NEXAFS spectra corresponding to a perfect F8BT crystal oriented with the 1s – π^* transition dipole moment parallel and perpendicular to the electric field vector of a perfectly linearly polarized X‐ray beam.     

Injection molding of biodegradable polyester blends filled with mineral and sustainable fillers: Performance evaluation

This research focuses on the melt processing of biocomposites from a biodegradable polymer blend mixed with hybrid fillers through injection molding technique. An optimized blend ratio (60/40 wt%) poly(butylene succinate-co-butylene adipate) (PBSA) and poly(butylene adipate-co-terephthalate) (PBAT) demonstrated promising results after blending with a mixture of walnut shell powder (WSP), corn starch and talc in various proportions for use in rigid packaging. The addition of hybrid fillers (i) 10% WSP with 15% talc and (ii) 5% WSP with 5% starch and 15% talc to the polymer blend (60%PBSA/40%PBAT) improved tensile modulus (160% and 162%, respectively) and flexural modulus (147% and 153%, respectively) because of the dispersion of stiffer talc and WSP. Following the addition of fillers, tensile strength of the composites decreased. However, flexural strength improved significantly after filler introduction because of better stress transfer ability. Rheological analysis of filled composites with starch or WSP (25%) depicted similar characteristics of the polymer blend, indicating lower viscosity than hybrid composites. The abundant hydroxyl groups in starch explained the increased water absorption and decreased contact angle compared with other composites. This research's novelty encompasses utilizing low-cost biomasses with mineral filler into an under-researched biodegradable polymer blend suitable for single-use rigid packaging applications.     

Unexpected products and reaction mechanisms of the aqueous chlorination of cimetidine

Many pharmaceuticals and personal care products (PPCPs) resist degradation in wastewater treatment plants. Thus, they may be transformed by chemical disinfectants in the final treatment stage, generating products that may possess enhanced toxicity/biological activity relative to the parent compounds. For this reason, the reaction of cimetidine, an over-the-counter antacid, with the frequently used disinfectant, free chlorine, was investigated. Cimetidine degraded rapidly in the presence of excess free chlorine, indicating that it will likely undergo significant transformation during wastewater disinfection. Four major products were isolated and extensively characterized by comparison of liquid chromatographic retention times to known standards, mass spectrometry, 1H- and 2D-nuclear magnetic resonance spectroscopy, and infrared spectroscopy. An expected sulfur oxidation product, cimetidine sulfoxide, was identified along with three unexpected products: 4-hydroxymethyl-5-methyl-1H-imidazole, 4-chloro-5-methyl-1H-imidazole, and a product proposed to be either a beta- or delta-sultam. The last three products are formed by transformations not frequently observed in free chlorine reactions of PPCPs such as C-C bond cleavage and intramolecular nucleophilic substitution. The unexpected transformations yielded compounds with more substantial structural changes than would be observed in common free chlorine reactions such as N-chlorination or electrophilic halogenation. The reaction pathway was elucidated by kinetic analysis and by independently treating isolated intermediates with free chlorine, and reaction mechanisms were proposed. Finally, the predicted no-effect concentration (PNEC) of the chlorination products was estimated, and the products 4-hydroxymethyl-5-methyl-1H-imidazole and 4-chloro-5-methyl-1H-imidazole were estimated to have lower PNECs than cimetidine.     

Association with natural organic matter enhances the sunlight-mediated inactivation of MS2 coliphage by singlet oxygen

MS2 coliphage, a surrogate for human enteric viruses, is inactivated by singlet oxygen (1O2) produced via sunlight-mediated excitation of natural organic matter (NOM) in surface waters. The 1O2 concentration within a NOM macromolecule or supramolecular assembly ([1O2]internal) is orders of magnitude higher than in the bulk solution ([1O2]bulk). In close proximity of NOM, MS2 is thus exposed to an elevated 1O2 concentration ([1O2]NOM), and inactivation is likely to be enhanced as compared to the bulk solution. In experiments using a solar simulator, we determined [1O2]bulk, [1O2]internal, as well as the association of MS2 with four NOMs (Fluka humic acid, FHA; Suwannee river humic acid, SRHA; Aldrich humic acid, AHA; Pony lake fulvic acid, PLFA), and studied their effect on the MS2 inactivation rate constant, k(obs), over a range of 1-25 mg NOM/L. The k(obs) values were modeled as the sum of the inactivation rate constants in close proximity to the NOM and in the bulk solution, assuming Langmuir-type adsorption of NOM onto MS2. FHA and SRHA exhibited 13-22 fold greater adsorption equilibrium constants than AHA and PLFA. Inactivation in the bulk solution contributed between 2% (20 mg/L FHA) and 39% (5 mg/L AHA) toward the overall k(obs). Thus, even for the less adsorbing NOM, inactivation was dominated by [1O2]NOM rather than [1O2]bulk. Changes in solution chemistry to promote closer interactions between MS2 and NOM also enhanced k(obs). Addition of Mg2+ to neutralize the negative surface charge of MS2 and NOM increased k(obs) up to 4.1-fold. Similarly, lowering the solution pH closer to the isoelectric point of MS2 (pl = 3.9) enhanced k(ob), 51-fold in 5 mg/L AHA.     

European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health

Rationale: This statement is an updated version of one released by the same authors in February 2003. The statement was produced to follow up the Royal College of Physicians (RCP) Tobacco Advisory Group report "Protecting smokers, saving lives: the case for a tobacco and nicotine regulatory authority",¹ which argued for an evidence based regulatory approach to smokeless tobacco and harm reduction and posed a series of questions that regulators must address in relation to smokeless tobacco.

The purpose of this statement is to provide arguments of fact and principle to follow the RCP's report and to outline the public health case for changing existing European Union (EU) regulation in this area. A review of regulation in relation to harm reduction and regulation of tobacco products other than cigarettes is required in Article 11 of EU directive 2001/37/EC,² and this is a contribution towards forming a consensus in the European public health community about what policy the EU should adopt in the light of this review, or following ongoing legal action that may potentially strike out the existing regulation altogether.

Public health case: We believe that the partial ban applied to some forms of smokeless tobacco in the EU should be replaced by regulation of the toxicity of all smokeless tobacco. We hold this view for public health reasons: smokeless tobacco is substantially less harmful than smoking and evidence from Sweden suggests it is used as a substitute for smoking and for smoking cessation. To the extent there is a "gateway" it appears not to lead to smoking, but away from it and is an important reason why Sweden has the lowest rates of tobacco related disease in Europe. We think it is wrong to deny other Europeans this option for risk reduction and that the current ban violates rights of smokers to control their own risks. For smokers that are addicted to nicotine and cannot or will not stop, it is important that they can take advantage of much less hazardous forms of nicotine and tobacco—the alternative being to "quit or die"... and many die. While nicotine replacement therapies (NRT) may have a role in harm reduction, tobacco based harm reduction options may reach more smokers and in a different, market based, way. Chewing tobacco is not banned or regulated in the EU but is often highly toxic, and our proposal could remove more products from the market than it permitted.

Regulatory options: We believe that the EU policy on smokeless tobacco should adapt to new scientific knowledge and that the European Commission should bring forward proposals to amend or replace Article 8 of directive 2001/37/EC with a new regulatory framework. Canada has developed testing regimens for tobacco constituents and these could be readily adapted to the European situation. A review of EU policy in this area is required no later than December 2004, and we believe the Commission should expedite the part of its review that deals with harm reduction and regulation of tobacco products other than cigarettes so as to reconsider its policy on smokeless tobacco. We held this view before Swedish Match brought its legal proceedings to challenge EU legislation and we will continue to hold these views if its action fails.

     

Whither tobacco product regulation?

Despite decades of industry innovation and regulatory efforts, the harmfulness of conventional cigarettes has not changed. There are several pitfalls in this area, including the long time lag before health impacts of product regulatory changes become apparent, the danger of consumers deriving false reassurance of lesser harm in the interim period, the lack of relevant expertise and the lack of an internationally agreed and evidence-based strategic approach. Articles 9 and 10 of the Framework Convention on Tobacco Control provide the potential for such a global strategy, and knowledge and research has increased significantly over recent years. However, there are huge opportunity costs in implementing product disclosure and regulatory strategies: most national regulators have very limited human and financial resources, which should be focused on other evidence-based tobacco control interventions. We believe therefore that it is now time to abandon the notion of safe or safer cigarettes while moving consumers towards cleaner nicotine products as soon as possible. In parallel to this, we recommend a number of other strategies be implemented including: reducing the appeal of all tobacco products, forbidding new tobacco products or brand variants being marketed without evidence of reduced harm, appeal or addictiveness, and developing a tobacco industry resourced, but industry independent, Framework Convention on Tobacco Control global repository to assist national regulators in understanding and regulating the products on their markets.     

Water hardness as a photochemical parameter: tetracycline photolysis as a function of calcium concentration, magnesium concentration, and pH

The environmental photochemical kinetics of the antibiotic compound tetracycline were investigated. The aqueous speciation of tetracycline over a range of natural pH and water hardness values is dominated by association with Ca2+ and Mg2+ ions. The association constants necessary to calculate tetracycline aqueous speciation given knowledge of pH, [Ca2+], and [Mg2+] were measured by spectrophotometric titrations and matrix deconvolution of a series of UV-vis absorption spectra into individual component species. A series of photolysis experiments was performed under simulated sunlight, and quantum yields for the solar photolysis of each environmentally relevant species were calculated. The results indicate that the pseudo-first-order rate constant for tetracycline photolysis at varied Mg2+ and Ca2+ concentrations relevant to natural conditions can vary by up to an order of magnitude. A self-sensitization effect was observed and was accounted for by varying the initial tetracycline concentration under each set of photolysis conditions.     

Changes in supervision as counselors and therapists gain experience: A review.

Considerable research relevant to counselor and therapist development has been done since E. L. Worthington's (see record 1988-21517-001) review. Additional support has surfaced for Worthington's conclusions: There is support for general developmental models, perceptions of supervisors and supervisees are consistent with developmental theories, the behaviors of supervisors change as counselors gain experience, and the supervision relationship changes as counselors gain experience. Although the types of research used and the sophistication of data analysis have improved somewhat, too few studies directly address changes over time for trainees in supervision. Suggestions are given for future research in supervision to reflect the level of specificity necessary to investigate developmental models. (PsycINFO Database Record (c) 2010 APA, all rights reserved)